Ph 2: Carfilzomib & lenalidomide-based treatment for newly diagnosed primary plasma cell leukemia

EMN12/HOVON129 Study

Phase 2: To evaluate progression-free survival in adult pPCL patients by incorporation of carfilzomib and lenalidomide in induction, consolidation, and maintenance therapy

Carfilzomib and lenalidomide-based treatment for younger and elderly newly diagnosed primary plasma cell leukemia patients.

HOVON HO129 PCL

Multicenter, intergroup, phase 2 study

---

Carfilzomib and lenalidomide-based treatment for younger and elderly newly diagnosed primary plasma cell leukemia patients.

Start Date: 2015-08-10

Stop Date: 2023-08-10

Netherlands Trial Register - Trial NL5202 (NTR5350)

https://www.trialregister.nl/trial/5202